Stephen Long

Capsaicin 8% Patch in Painful Diabetic Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study

David M. Simpson, Jessica Robinson‐Papp, Joanna Van et al. · Journal of Pain · 2016 · 170 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study

Aaron I. Vinik, Serge Perrot, Etta J. Vinik et al. · BMC Neurology · 2016 · 105 citations · Full text

Pharmacy, Pharmacotherapy, Diabetic Foot Care +16

SLV313 (1-(2,3-Dihydro-Benzo[1,4]Dioxin-5-yl)-4- [5-(4-Fluoro-Phenyl)-Pyridin-3-ylmethyl]-Piperazine Monohydrochloride): A Novel Dopamine D2 Receptor Antagonist and 5-HT1A Receptor Agonist Potential Antipsychotic Drug

Andrew C. McCreary, Jeffrey Glennon, Charles R. Ashby et al. · Neuropsychopharmacology · 2006 · 58 citations

Medicine, Neuroscience, Pharmacology +14

New 1-aryl-4-(biarylmethylene)piperazines as potential atypical antipsychotics sharing dopamine D2-receptor and serotonin 5-HT1A-receptor affinities

Rolf W. Feenstra, Janpeter de Moes, Jos J. Hofma et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 40 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): A novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist

Jeffrey Glennon, Guus van Scharrenburg, Eric Ronken et al. · Synapse · 2006 · 39 citations

Medicine, Medicinal Chemistry, Pharmacology +17